Unsupported Browser
The American College of Surgeons website is not compatible with Internet Explorer 11, IE 11. For the best experience please update your browser.
Menu
Become a member and receive career-enhancing benefits

Our top priority is providing value to members. Your Member Services team is here to ensure you maximize your ACS member benefits, participate in College activities, and engage with your ACS colleagues. It's all here.

Become a Member
Become a member and receive career-enhancing benefits

Our top priority is providing value to members. Your Member Services team is here to ensure you maximize your ACS member benefits, participate in College activities, and engage with your ACS colleagues. It's all here.

Become a Member
ACS
Cancer Programs

Clarification on Standard 9.1: Clinical Research Accrual

September 19, 2024

The CoC and NAPBC confirm that enrollment of patients in retrospective studies cannot be counted toward accrual for CoC or NAPBC Standard 9.1: Clinical Research Accrual.

Retrospective research studies are observational studies designed to answer clinical questions through the analysis of data that have already been collected. This may include chart reviews or audits, or the review of available data from cancer registries or databases.

The intent of Standard 9.1 is to support enrollment of eligible patients in active cancer-related clinical trials and research studies that advance the science of cancer research and help provide the highest quality of care to patients with cancer. Accordingly, the CoC and NAPBC have clarified that retrospective research studies do not qualify for patient accrual for Standard 9.1.

In addition to meeting all the requirements outlined in Standard 9.1, research studies that are eligible for patient accrual must include future action on the part of the patient or the accredited cancer program, and/or the clinical researchers.

Questions regarding the CoC and NAPBC accreditation standards should be submitted through the CAnswer Forum.